Evidence map›Paper›PMID 35307504›Full record

ArticleBrain, behavior, and immunity2022

Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish.

Aurora Kraus, Mar Huertas, Laura Ellis, Pierre Boudinot, Jean-Pierre Levraud, Irene Salinas

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Zebrafish (International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Inflammation in Development and Aging: Insights from the Zebrafish Model.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. A micro-sized vaccine based on recombinantActa pharmaceutica Sinica. B · 2023
    Article
  16. Article
  17. Zebrafish models of COVID-19.FEMS microbiology reviews · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Aurora KrausCenter of Evolutionary and Theoretical Immunology, Biology Department, University of New Mexico, NM, USA.
Mar HuertasDepartment of Biology, Texas State University, San Marcos, TX, USA.
Laura EllisDepartment of Biology, Texas State University, San Marcos, TX, USA.
Pierre BoudinotUniversité Paris-Saclay, INRAE, UVSQ, VIM, 78350 Jouy-en-Josas, France.
Jean-Pierre LevraudUnité Macrophages et Développement de l'Immunité, Institut Pasteur, CNRS UMR3637, Paris, France.
Irene SalinasCenter of Evolutionary and Theoretical Immunology, Biology Department, University of New Mexico, NM, USA. Electronic address: isalinas@unm.edu.
Texas State University · USCentre National de la Recherche Scientifique · FREvolutionary Genomics (United States) · USVirologie et Immunologie Moléculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anosmia, loss of smell, is a prevalent symptom of SARS-CoV-2 infection. Anosmia may be explained by several mechanisms driven by infection of non-neuronal cells and damage in the nasal epithelium rather than direct infection of olfactory sensory neurons (OSNs). Previously, we showed that viral proteins are sufficient to cause neuroimmune responses in the teleost olfactory organ (OO). We hypothesize that SARS-CoV-2 spike (S) protein is sufficient to cause olfactory damage and olfactory dysfunction. Using an adult zebrafish model, we report that intranasally delivered SARS-CoV-2 S RBD mostly binds to the non-sensory epithelium of the olfactory organ and causes severe olfactory histopathology characterized by loss of cilia, hemorrhages and edema. Electrophysiological recordings reveal impaired olfactory function to both food and bile odorants in animals treated intranasally with SARS-CoV-2 S RBD. However, no loss of behavioral preference for food was detected in SARS-CoV-2 S RBD treated fish. Single cell RNA-Seq of the adult zebrafish olfactory organ indicated widespread loss of olfactory receptor expression and inflammatory responses in sustentacular, endothelial, and myeloid cell clusters along with reduced numbers of T

Indexed as

COVID-19Spike Glycoprotein, CoronavirusAnimalsAnosmiaCOVID-19 VaccinesHumansInflammationOlfactory MucosaSARS-CoV-2ZebrafishCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Animal modelsEOGOlfactory damageOlfactory receptor expressionSARS-CoV-2Spike proteinZebrafish (Danio rerio)

Identifiers

PMID35307504
PMCPMC8929544
OpenAlexW4221100374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.